Table 4. Distribution of diagnostic groups among the patients with a highest Pediatric Early Warning Score (PEWS) ≥3 compared to the patients with a highest PEWS of 0−2.
PEWS ≥3 | PEWS 0–2 | p-value | Total | |
Injury* | 3/123 (2.4%) | 89/638 (13.9%) | <0.001 | 92/761 (12.1%) |
Congenital cardiovascular disease* | 5/123 (4.1%) | 5/638 (0.8%) | <0.001 | 10/761 (1.3%) |
Acquired cardiovascular disease* | 4/123 (3.3%) | 11/683 (1.6%) | <0.001 | 15/761 (2.0%) |
Neurological disease* | 8/123 (17.9%) | 100/638 (11.8%) | 0.007 | 108/761 (14.2%) |
Renal disease including urinary tract infection* | 3/123 (2.4%) | 23/638 (3.6%) | <0.001 | 26/761 (3.4%) |
Gastrointestinal disease* | 15/123 (12.2%) | 142/638 (22.3%) | 0.011 | 157/761 (20.6%) |
Respiratory, upper airway disease* | 9/123 (7.3%) | 71/638 (11.1%) | <0.001 | 80/761 (10.5%) |
Respiratory, lower airway disease* | 57/123 (46.4%) | 54/638 (8.5%) | <0.001 | 111/761 (14.6%) |
‘Other infection’* | 8/123 (6.5%) | 53/638 (8.3%) | <0.001 | 61/761 (8.0%) |
Miscellaneous including dehydration and diabetes ketoacidosis | 11/123 (8.9%) | 90/638 (14.1%) | 0.15 | 82/761 (10.8%) |
p<0.05 is considered a significant difference (marked with *).